Edition:
United States

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

4.47USD
4:00pm EDT
Change (% chg)

$-0.18 (-3.87%)
Prev Close
$4.65
Open
$4.57
Day's High
$4.65
Day's Low
$4.09
Volume
213,493
Avg. Vol
130,982
52-wk High
$84.90
52-wk Low
$3.56

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.42 -10.347
Mar '18 2.69 -7.543
FY 2017 Dec '17 2.81 -19.189
Sep '17 4.59 -61.574
Jun '17 3.04 -7.730
Mar '17 0.30 -20.503
FY 2016 Dec '16 1.08 -13.816
Sep '16 0.90 -21.269
Jun '16 0.75 -0.247
Mar '16 0.50 -0.241
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 3.52 3.52 3.52 --
Year Ending Dec-18 1 11.15 11.15 11.15 --
Earnings (per share)
Quarter Ending Dec-18 1 -2.80 -2.80 -2.80 --
Year Ending Dec-18 1 -21.87 -21.87 -21.87 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta 2.65 0.63 0.87
Price to Sales (TTM) 1.63 109.82 6.55
Price to Book (MRQ) 0.17 13.72 4.00
Price to Tangible Book (MRQ) -- 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg 234.44 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -20.44 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago 135.00 91.25 6.56
Sales - 5 Yr. Growth Rate -15.67 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago -33.85 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago -55.81 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 1.68 5.52 2.99
LT Debt to Equity (MRQ) 0.00 15.33 11.31
Total Debt to Equity (MRQ) 3.61 18.80 14.15
Interest Coverage (TTM) -95.08 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -146.73 -- --
EBITD - 5 Yr. Avg -91.62 -164.07 16.13
Operating Margin (TTM) -439.27 -618.88 3.36
Operating Margin - 5 Yr. Avg. -166.11 -178.92 11.28
Pre-Tax Margin (TTM) -465.12 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -167.08 -181.48 11.54
Net Profit Margin (TTM) -399.10 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -154.60 -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 416,963 24,741,437 725,680,242
Net Income/Employee (TTM) -1,664,097 1,102,410 84,001,075
Receivable Turnover (TTM) 3.89 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.18 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -69.85 0.35 9.83
Return on Assets - 5 Yr. Avg. -58.10 3.11 10.94
Return on Investment (TTM) -76.60 1.96 12.83
Return on Investment - 5 Yr. Avg. -69.32 2.91 14.05
Return on Equity (TTM) -102.48 1.12 14.95
Return on Equity - 5 Yr. Avg. -86.80 -0.97 15.39
  1 Year 3 Year 5 Year
Sales % 231.82 1.76 -15.67
EPS (TTM) % -136.67 -- --
Dividend % -100.00 -- --
Note: Units in Millions of US Dollars

Performance for Altimmune Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.14%
# of Holders: 32
Total Shares Held: 458,897
3 Mo. Net Change: 302,278
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.